Dr. David Edward Hale Jr., MD

Dr. Hale practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Hale's NPI, 1972064897, was assigned on March 26, 2019. Dr. Hale graduated from Pennsylvania State University College of Medicine in 2019. Dr. Hale holds Maryland license D97738.

Dr. Hale's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Hale's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Hale is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Hale to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hale practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hale's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Hale's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 317 Medicare services from Dr. Hale across 8 procedure codes in 2024, for 175 Medicare patients. Medicare paid $24,393 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 175 Medicare patients who saw Dr. Hale in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hale's median patient age at 71, with 66% women.

In 2024, Dr. Hale wrote 44 Medicare Part D claims for 22 patients. 91% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $308 in total drug cost. In 2022, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hale for performance year 2024, reported as part of a group. CMS lists Dr. Hale as offering telehealth.

Dmand AI links 5 papers to Dr. Hale, published from 2021 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Diagnosis, Differential. Dr. Hale has published most often in Neurology. Dr. Hale's most frequent co-authors are Kemar Green Green, DO, Anand Kumar Bery, MD and David Edward Newman-Toker, MD.

CMS Open Payments shows 1 general payment to Dr. Hale from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Catalyst Pharmaceuticals, Inc. paid the most, $62.

Dr. Hale graduated from Pennsylvania State University College of Medicine in 2019.